Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro

Inflammation Research

Volumn 64, Issue 6, 2015, Pages 423-431

  Wang, Wenping ^a   Xia, Tingsong ^a   Yu, Xinpu ^a  

^a JIANGYIN PEOPLE S HOSPITAL   (China)

Author keywords

Caco 2 cells; Intestinal barrier function; Intestinal inflammation; NF B; TLR4; Wogonin

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; AUTACOID; CLAUDIN 1; FLAVANONE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN DERIVATIVE; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MYD88 PROTEIN, HUMAN; MYELOID DIFFERENTIATION FACTOR 88; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4; WOGONIN;

ACTIVE TRANSPORT; BIOSYNTHESIS; CACO 2 CELL LINE; DRUG EFFECTS; GENETICS; HUMAN; IMPEDANCE; INTESTINE; METABOLISM; SIGNAL TRANSDUCTION;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BIOLOGICAL TRANSPORT, ACTIVE; CACO-2 CELLS; CLAUDIN-1; ELECTRIC IMPEDANCE; FLAVANONES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; INTESTINES; MAP KINASE KINASE KINASES; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84937761775     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-015-0822-0     Document Type: Article

References (26)

1. McGilligan VE, Wallace JM, Heavey PM, Ridley DL, Rowland IR. Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis. Inflamm Bowel Dis. 2007;13:108–15.
2. Potack J, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease. Gut Liver. 2008;2:61–73.
3. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427–34.
4. Su L, Shen L, Clayburgh DR, Nalle SC, Sullivan EA, Meddings JB, Abraham C, Turner JR. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterology. 2009;136:551–63.
5. Bhattacharyya S, Gill R, Chen ML, Zhang F, Linhardt RJ, Dudeja PK, Tobacman JK. Toll-like receptor 4 mediates induction of the Bcl10-NFkappaB-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. J Biol Chem. 2008;283:10550–8.
6. Al-Sadi RM, Ma TY. IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol. 2007;178:4641–9.
7. Chiu YH, Lu YC, Ou CC, Lin SL, Tsai CC, Huang CT, Lin MY. Lactobacillus plantarum MYL26 induces endotoxin tolerance phenotype in Caco-2 cells. BMC Microbiol. 2013;13:190.
8. McElroy SJ, Hobbs S, Kallen M, Tejera N, Rosen MJ, Grishin A, Matta P, Schneider C, Upperman J, Ford H, Polk DB, Weitkamp JH. Transactivation of EGFR by LPS induces COX-2 expression in enterocytes. PLoS One. 2012;7:e38373.
9. Dou W, Zhang J, Li H, Kortagere S, Sun K, Ding L, Ren G, Wang Z, Mani S. Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway. J Nutr Biochem. 2014;25:923–33.
10. Tai MC, Tsang SY, Chang LY, Xue H. Therapeutic potential of wogonin: a naturally occurring flavonoid. CNS Drug Rev. 2005;11:141–50.
11. Chi YS, Lim H, Park H, Kim HP. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem Pharmacol. 2003;66:1271–8.
12. Huang WH, Lee AR, Yang CH. Antioxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis GEORGI. Biosci Biotechnol Biochem. 2006;70:2371–80.
13. Wakabayashi I, Yasui K. Wogonin inhibits inducible prostaglandin E(2) production in macrophages. Eur J Pharmacol. 2000;406:477–81.
14. Lee H, Kim YO, Kim H, Kim SY, Noh HS, Kang SS, Cho GJ, Choi WS, Suk K. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J. 2003;17:1943–4.
15. Huang GC, Chow JM, Shen SC, Yang LY, Lin CW, Chen YC. Wogonin but not Nor-wogonin inhibits lipopolysaccharide and lipoteichoic acid-induced iNOS gene expression and NO production in macrophages. Int Immunopharmacol. 2007;7:1054–63.
16. Piao HZ, Choi IY, Park JS, Kim HS, Cheong JH, Son KH, Jeon SJ, Ko KH, Kim WK. Wogonin inhibits microglial cell migration via suppression of nuclear factor-kappa B activity. Int Immunopharmacol. 2008;8:1658–62.
17. Chen CC, Hung TH, Wang YH, Lin CW, Wang PY, Lee CY, Chen SF. Wogonin improves histological and functional outcomes, and reduces activation of TLR4/NF-kappaB signaling after experimental traumatic brain injury. PLoS One. 2012;7:e30294.
18. 2-induced vascular permeability through suppressing the phosphorylation of caveolin-1. Toxicology. 2013;305:10–9.
19. Huynh-Delerme C, Huet H, Noel L, Frigieri A, Kolf-Clauw M. Increased functional expression of P-glycoprotein in Caco-2 TC7 cells exposed long-term to cadmium. Toxicol In Vitro. 2005;19:439–47.
20. Lopez-Posadas R, Ballester I, Mascaraque C, Suarez MD, Zarzuelo A, Martinez-Augustin O, Sanchez de Medina F. Flavonoids exert distinct modulatory actions on cyclooxygenase 2 and NF-kappaB in an intestinal epithelial cell line (IEC18). Br J Pharmacol. 2010;160:1714–26.
21. Sina C, Arlt A, Gavrilova O, Midtling E, Kruse ML, Muerkoster SS, Kumar R, Folsch UR, Schreiber S, Rosenstiel P, Schafer H. Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB. Inflamm Bowel Dis. 2010;16:320–31.
22. Richter JM, Schanbacher BL, Huang H, Xue J, Bauer JA, Giannone PJ. LPS-binding protein enables intestinal epithelial restitution despite LPS exposure. J Pediatr Gastroenterol Nutr. 2012;54:639–44.
23. Stahl M, Ries J, Vermeulen J, Yang H, Sham HP, Crowley SM, Badayeva Y, Turvey SE, Gaynor EC, Li X, Vallance BA. A novel mouse model of Campylobacter jejuni gastroenteritis reveals key pro-inflammatory and tissue protective roles for Toll-like receptor signaling during infection. PLoS Pathog. 2014;10:e1004264.
24. Chen L, Lin MJ, Zhan LL, Lv XP. Analysis of TLR4 and TLR2 polymorphisms in inflammatory bowel disease in a Guangxi Zhuang population. World J Gastroenterol. 2012;18:6856–60.
25. Lin YC, Huang DY, Chu CL, Lin YL, Lin WW. The tyrosine kinase Syk differentially regulates Toll-like receptor signaling downstream of the adaptor molecules TRAF6 and TRAF3. Sci Signal. 2013; 6:ra71.
26. Madera-Salcedo IK, Cruz SL, Gonzalez-Espinosa C. Morphine prevents lipopolysaccharide-induced TNF secretion in mast cells blocking IkappaB kinase activation and SNAP-23 phosphorylation: correlation with the formation of a beta-arrestin/TRAF6 complex. J Immunol. 2013;191:3400–9.